Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

This study is currently recruiting participants.
Verified February 2014 by Grifols Biologicals Inc.
Sponsor:
Information provided by (Responsible Party):
Grifols Biologicals Inc.
ClinicalTrials.gov Identifier:
NCT00323856
First received: May 8, 2006
Last updated: February 17, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2020
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)